|
LOC653653 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.42049999435545E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.74810174616391E-11 |
| Normal-vs-Stage2 |
4.628800E-04 |
| Normal-vs-Stage3 |
1.592020E-02 |
| Normal-vs-Stage4 |
9.568100E-02 |
| Stage1-vs-Stage2 |
9.383600E-01 |
| Stage1-vs-Stage3 |
1.404350E-03 |
| Stage1-vs-Stage4 |
4.863900E-03 |
| Stage2-vs-Stage3 |
4.414400E-02 |
| Stage2-vs-Stage4 |
5.248000E-02 |
| Stage3-vs-Stage4 |
8.747600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.98899999090696E-09 |
| Normal-vs-AfricanAmerican |
2.696300E-02 |
| Normal-vs-Asian |
1.507970E-01 |
| Caucasian-vs-AfricanAmerican |
9.853000E-01 |
| Caucasian-vs-Asian |
6.292000E-01 |
| AfricanAmerican-vs-Asian |
7.426200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.0246000027343E-08 |
| Normal-vs-Female |
1.60640000002044E-06 |
| Male-vs-Female |
5.964600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.200000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.76009999592375E-08 |
| Normal-vs-Age(61-80Yrs) |
2.32590000037725E-07 |
| Normal-vs-Age(81-100Yrs) |
5.687400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.457600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.311400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.465380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.171200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.490500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.538000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.942100E-03 |
| Normal-vs-Grade 2 |
3.21029980376863E-10 |
| Normal-vs-Grade 3 |
1.003340E-04 |
| Normal-vs-Grade 4 |
1.553030E-01 |
| Grade 1-vs-Grade 2 |
2.243400E-01 |
| Grade 1-vs-Grade 3 |
3.465700E-02 |
| Grade 1-vs-Grade 4 |
3.781400E-03 |
| Grade 2-vs-Grade 3 |
2.120300E-02 |
| Grade 2-vs-Grade 4 |
2.004500E-03 |
| Grade 3-vs-Grade 4 |
1.399830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.612699028821E-11 |
| Normal-vs-ccB subtype |
4.31469999995215E-06 |
| ccA subtype-vs-ccB subtype |
2.761600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54529999907282E-08 |
| Normal-vs-N1 |
2.736600E-01 |
| N0-vs-N1 |
5.171000E-01 |
|
|
